Pulse Biosciences (PLSE)

• Market cap: $1.06B
• 1 day: -2.54%
• 5 days: 5.56%
• 1 month: 7.66%
• 3 months: -11.70%
• 6 months: -2.92%
• Year to date: -2.81%
• 1 year: 152.41%
• 5 years: 163.17%
• 10 years: 314.63%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Employees: 56

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

94% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 16

86% more call options, than puts

Call options by funds: $1.75M | Put options by funds: $941K

18% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 11

5% more capital invested

Capital invested by funds: $98.4M [Q3] → $104M (+$5.3M) [Q4]

0.56% more ownership

Funds ownership: 9.17% [Q3] → 9.73% (+0.56%) [Q4]

0% more funds holding

Funds holding: 72 [Q3] → 72 (+0) [Q4]